Business August 20, 2020
Johnson & Johnson to acquire Momenta Pharmaceuticals for 6.5B
Johnson & Johnson (NYSE: JNJ) announced its decision to acquire Momenta Pharmaceuticals (NASDA: MNTA) for $6.5 billion in an all-cash…
Business August 20, 2020
Johnson & Johnson (NYSE: JNJ) announced its decision to acquire Momenta Pharmaceuticals (NASDA: MNTA) for $6.5 billion in an all-cash…
By Marivic Cabural Summers